AMA Releases Full Language Of New CPT Code For Psychedelic Therapies, Goes Into Effect January 2024

The American Medical Association (AMA) released language for new Current Procedural Terminology (CPT) III code for continuous in-person monitoring and intervention during psychedelic medication therapy, such as with psilocybin or MDMA. The code is slated to go into effect and be published in the CPT manual on January 1, 2024. Once effective, the CPT code will provide physicians and other qualified health care professionals with a means to code and seek reimbursement for delivering psychedelic therapies.

The code was approved in May 2023 after being submitted in a joint application by COMPASS Pathways plc and MAPS Public Benefit Corporation . . .